Amaurosis: Difference between revisions

Jump to navigation Jump to search
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
(No difference)

Revision as of 22:03, 8 August 2012

Amaurosis

WikiDoc Resources for Amaurosis

Articles

Most recent articles on Amaurosis

Most cited articles on Amaurosis

Review articles on Amaurosis

Articles on Amaurosis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Amaurosis

Images of Amaurosis

Photos of Amaurosis

Podcasts & MP3s on Amaurosis

Videos on Amaurosis

Evidence Based Medicine

Cochrane Collaboration on Amaurosis

Bandolier on Amaurosis

TRIP on Amaurosis

Clinical Trials

Ongoing Trials on Amaurosis at Clinical Trials.gov

Trial results on Amaurosis

Clinical Trials on Amaurosis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Amaurosis

NICE Guidance on Amaurosis

NHS PRODIGY Guidance

FDA on Amaurosis

CDC on Amaurosis

Books

Books on Amaurosis

News

Amaurosis in the news

Be alerted to news on Amaurosis

News trends on Amaurosis

Commentary

Blogs on Amaurosis

Definitions

Definitions of Amaurosis

Patient Resources / Community

Patient resources on Amaurosis

Discussion groups on Amaurosis

Patient Handouts on Amaurosis

Directions to Hospitals Treating Amaurosis

Risk calculators and risk factors for Amaurosis

Healthcare Provider Resources

Symptoms of Amaurosis

Causes & Risk Factors for Amaurosis

Diagnostic studies for Amaurosis

Treatment of Amaurosis

Continuing Medical Education (CME)

CME Programs on Amaurosis

International

Amaurosis en Espanol

Amaurosis en Francais

Business

Amaurosis in the Marketplace

Patents on Amaurosis

Experimental / Informatics

List of terms related to Amaurosis


Amaurosis (Greek meaning darkening, dark, or obscure) is vision loss or weakness that occurs without an apparent lesion affecting the eye [1]. It may result from either a medical condition or from excess acceleration, as in flight. The term is the same as the Latin gutta serena.

Types

Leber's congenital amaurosis is an inherited disease resulting in severe vision loss or blindness that was first described by Theodore Leber in the 19th century.

Amaurosis fugax (Latin: fugax meaning fugitive) is a temporary loss of vision in one eye caused by decreased blood flow (ischemia) to the retina. Another cause is the presence of emboli located in the ipsilateral(same side) internal carotid artery. It is a type of transient ischaemic attack (TIA). Those experiencing Amaurosis usually experience complete symptom abeyance within a few minutes. In a small minority of those who experience Amaurosis, stroke or vision loss has resulted. Diabetes, hypertension and smoking are factors known to increase the risks of suffering this condition. It also can be the result of surgical repair to the mitral valve, when very small emboli may break away from the site of the repair, while the patient's tissue grows to cover the plastic Annuloplasty band.

This condition can also occur in ruminants suffering from a vitamin B1 (Thiamin) deficiency due to Thiamine-Related Cerebrocortical Necrosis (CCN).

Management

Those experiencing amaurosis are usually advised to consult a physician immediately as any form of vision loss, even if temporary, is a symptom that may indicate the presence of a serious ocular or systemic problem.


Template:WikiDoc Sources